Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cotton

Showing results (351-360 of 474) with videos related to

Pageof 48
Sort By:
AIDS Care|July 9, 2019
Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South AfricaP E Springer, A L Slogrove, M Kidd, et al.
AIDS Research and Therapy|September 30, 2021
Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trialHelen Payne, Man K Chan, Sarah A Watters, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 4, 2017
Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041B Zeldow, S Kim, G McSherry, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 13, 2004
Guideline for the management of upper respiratory tract infectionsA J Brink, M F Cotton, C Feldman, et al.
BMC Medicine|July 19, 2014
The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of lifeVivek Naranbhai, Soyeon Kim, Helen Fletcher, et al.
AIDS (London, England)|January 16, 2018
Rapid decline of HIV-1 DNA and RNA in infants starting very early antiretroviral therapy may pose a diagnostic challengeKirsten A Veldsman, Jean Maritz, Shahieda Isaacs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2003
Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected childrenA C Hesseling, H S Schaaf, W A Hanekom, et al.
BMC Research Notes|October 28, 2011
Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) StudyClotilde Hainline, Reghana Taliep, Gill Sorour, et al.
The Lancet. Infectious Diseases|June 6, 2015
Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysisHelen Payne, Nonhlanhla Mkhize, Kennedy Otwombe, et al.
Journal of the International AIDS Society|March 15, 2021
Tuberculosis infection and disease in South African adolescents with perinatally acquired HIV on antiretroviral therapy: a cohort studyLisa J Frigati, Katalin A Wilkinson, Stanzi le Roux, et al.
Pageof 48

Showing results (351-360 of 474) with videos related to

Sort By:
Pageof 48
AIDS Care|July 9, 2019
Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South AfricaP E Springer, A L Slogrove, M Kidd, et al.
AIDS Research and Therapy|September 30, 2021
Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trialHelen Payne, Man K Chan, Sarah A Watters, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 4, 2017
Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041B Zeldow, S Kim, G McSherry, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 13, 2004
Guideline for the management of upper respiratory tract infectionsA J Brink, M F Cotton, C Feldman, et al.
BMC Medicine|July 19, 2014
The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of lifeVivek Naranbhai, Soyeon Kim, Helen Fletcher, et al.
AIDS (London, England)|January 16, 2018
Rapid decline of HIV-1 DNA and RNA in infants starting very early antiretroviral therapy may pose a diagnostic challengeKirsten A Veldsman, Jean Maritz, Shahieda Isaacs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2003
Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected childrenA C Hesseling, H S Schaaf, W A Hanekom, et al.
BMC Research Notes|October 28, 2011
Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) StudyClotilde Hainline, Reghana Taliep, Gill Sorour, et al.
The Lancet. Infectious Diseases|June 6, 2015
Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysisHelen Payne, Nonhlanhla Mkhize, Kennedy Otwombe, et al.
Journal of the International AIDS Society|March 15, 2021
Tuberculosis infection and disease in South African adolescents with perinatally acquired HIV on antiretroviral therapy: a cohort studyLisa J Frigati, Katalin A Wilkinson, Stanzi le Roux, et al.
Pageof 48